SANSER MEDICAL LIMITEDActive

Company number 08412464Private limited companyIncorporated 2013
⚠ Confirmation statement overdue. It was due on 24 Oct 2026.

Key figures

−£2,181-206.1%
Net assets 2025/26
-100 k0100 k200 k300 k2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, SANSER MEDICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand38,51632,98411,6478,3231,080
Total assets990,718743,507568,575551,328531,342
Total liabilities858,825623,327564,810—533,586
Net assets / total equity133,211121,0394,2802,056-2,181
Average number of employees11000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SANSER MEDICAL LIMITED

Company

SANSER MEDICAL LIMITED is a private limited company registered with Companies House under company number 08412464. It was incorporated on 20 Feb 2013. Its status is active. The registered office is in Wirral (CH48). Its nature of business (SIC 2007) is activities of patent and copyright agents; other legal activities n.e.c. (69109).

Accounts

The latest accounts in the database are for 2025/26 (period ending 28 Feb 2026); the company files small company accounts (filleted). Net assets were −£2,181, down 206.1% on the previous year. Cash at bank and in hand was £1,080. Total assets were £531,342 and total liabilities £533,586. The company had an average of 0 employees. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 24 Oct 2026.